Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001585364-25-000071
Filing Date
2025-05-16
Accepted
2025-05-16 11:52:01
Documents
1
Period of Report
2025-05-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1747410714.html 4  
1 FORM 4 wk-form4_1747410714.xml 4 8877
  Complete submission text file 0001585364-25-000071.txt   10402
Mailing Address 515 EASTERN AVENUE ALLEGAN MI 49010
Business Address THE SHARP BUILDING HOGAN PLACE DUBLIN 2 L2 D02 TY74 269-673-8451
PERRIGO Co plc (Issuer) CIK: 0001585364 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MERISANT AVENUE JEAN-JACQUES ROUSSEAU 7 NEUCHATEL V8 CH-2000
Business Address
Manzone Albert (Reporting) CIK: 0001816333 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36353 | Film No.: 25957809